Somatic mutations in the histone methyltransferase KMT2D are frequently implicated in tumorigenesis and depending on the biologic context, this methyltransferase may exert either tumor suppressive or promoting functions [80,81]. This evidence concerns the gene PRDM9 and neoplasm.